Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002
- PMID: 17287716
Evaluation of a methodology for a collaborative multiple source surveillance network for autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2002
Abstract
Problem: Autism spectrum disorders (ASDs) encompass a spectrum of conditions, including autistic disorder; pervasive developmental disorders, not otherwise specified (PDD-NOS); and Asperger disorder. Impairments associated with ASDs can range from mild to severe. In 2000, in response to increasing public heath concern regarding ASDs, CDC established the Autism and Developmental Disabilities Monitoring (ADDM) Network. The primary objective of this ongoing surveillance system is to track the prevalence and characteristics of ASDs in the United States. ADDM data are useful to understand the prevalence of ASDs and have implications for improved identification, health and education service planning, and intervention for children with ASDs. Because complete, valid, timely, and representative prevalence estimates are essential to inform public health responses to ASDs, evaluating the effectiveness and efficiency of the ADDM methodology is needed to determine how well these methods meet the network's objective.
Reporting period: 2002.
Description of system: The ADDM Network is a multiple-source, population-based, active system for monitoring ASDs and other developmental disabilities. In 2002, data were collected from 14 collaborative sites. This report describes an evaluation conducted using guidelines established by CDC for evaluating public health surveillance systems and is based on examination of the following characteristics of the ADDM Network surveillance system: simplicity, flexibility, data quality, acceptability, representativeness, sensitivity, predictive value positive (PVP), timeliness, stability, data confidentiality and security, and sources of variability.
Results and interpretation: Using multiple sources for case ascertainment strengthens the system's representativeness, sensitivity, and flexibility, and the clinician review process aims to bolster PVP. Sensitivity and PVP are difficult to measure, but the ADDM methodology provides the best possible estimate currently available of prevalence of ASDs without conducting complete population screening and diagnostic clinical case confirmation. Although the system is dependent on the quality and availability of information in evaluation records, extensive quality control and data cleaning protocols and missing records assessments ensure the most accurate reflection of the records reviewed. Maintaining timeliness remains a challenge with this complex methodology, and continuous effort is needed to improve timeliness and simplicity without sacrificing data quality. The most difficult influences to assess are the effects of changes in diagnostic and treatment practices, service provision, and community awareness. Information sharing through education and outreach with site-specific stakeholders is the best mechanism for understanding the current climate in the community with respect to changes in service provision and public policy related to ASDs, which can affect prevalence estimates.
Public health actions: These evaluation results and descriptions can be used to help interpret the ADDM Network 2002 surveillance year data and can serve as a model for other public health surveillance systems, especially those designed to monitor the prevalence of complex disorders.
Similar articles
-
Prevalence of autism spectrum disorders--Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008.MMWR Surveill Summ. 2012 Mar 30;61(3):1-19. MMWR Surveill Summ. 2012. PMID: 22456193
-
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.MMWR Surveill Summ. 2007 Feb 9;56(1):12-28. MMWR Surveill Summ. 2007. PMID: 17287715
-
Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, six sites, United States, 2000.MMWR Surveill Summ. 2007 Feb 9;56(1):1-11. MMWR Surveill Summ. 2007. PMID: 17287714
-
Public health monitoring of developmental disabilities with a focus on the autism spectrum disorders.Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):22-7. doi: 10.1002/ajmg.c.30006. Am J Med Genet C Semin Med Genet. 2004. PMID: 14755430 Review.
-
[Autism spectrum disorders in adults].Ned Tijdschr Geneeskd. 2008 Jun 14;152(24):1365-9. Ned Tijdschr Geneeskd. 2008. PMID: 18664213 Review. Dutch.
Cited by
-
Sex differences in the evaluation and diagnosis of autism spectrum disorders among children.Disabil Health J. 2010 Apr;3(2):107-16. doi: 10.1016/j.dhjo.2009.07.001. Epub 2009 Nov 8. Disabil Health J. 2010. PMID: 21122776 Free PMC article.
-
State-Level Trends in the Prevalence of Autism Spectrum Disorder (ASD) from 2000 to 2012: A Reanalysis of Findings from the Autism and Developmental Disabilities Network.J Autism Dev Disord. 2018 Sep;48(9):3086-3092. doi: 10.1007/s10803-018-3568-z. J Autism Dev Disord. 2018. PMID: 29654453 Free PMC article.
-
Nervous system disorders across the life course in resource-limited settings.Nature. 2015 Nov 19;527(7578):S167-71. doi: 10.1038/nature16031. Nature. 2015. PMID: 26580323 Free PMC article. Review.
-
Autism spectrum disorder prevalence and proximity to industrial facilities releasing arsenic, lead or mercury.Sci Total Environ. 2015 Dec 1;536:245-251. doi: 10.1016/j.scitotenv.2015.07.024. Epub 2015 Jul 25. Sci Total Environ. 2015. PMID: 26218563 Free PMC article.
-
Prevalence of Autism Spectrum Disorders in Guanajuato, Mexico: The Leon survey.J Autism Dev Disord. 2016 May;46(5):1669-85. doi: 10.1007/s10803-016-2696-6. J Autism Dev Disord. 2016. PMID: 26797939
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials